多瑞医药
(301075)
| 流通市值：66.76亿 | | | 总市值：66.76亿 |
| 流通股本：8000.00万 | | | 总股本：8000.00万 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 65,444,163.82 | 85,278,030.5 | 253,435,579.28 | 227,644,668.85 |
| 交易性金融资产 | 0 | 20,038,583.78 | 80,000,000 | 105,128,000 |
| 应收票据及应收账款 | 107,989,282.37 | 87,680,288.1 | 82,485,444.04 | 116,519,723.35 |
| 其中：应收票据 | 8,670,499.71 | 7,583,553.55 | 2,043,486.57 | 9,872,950.31 |
| 应收账款 | 99,318,782.66 | 80,096,734.55 | 80,441,957.47 | 106,646,773.04 |
| 应收款项融资 | 410,076 | 214,046.16 | 289,849.45 | 0 |
| 预付款项 | 8,748,736.94 | 10,244,543.34 | 45,398,558.18 | 36,080,572.68 |
| 其他应收款合计 | 20,648,665.81 | 17,087,031.49 | 10,500,738.75 | 9,699,404.63 |
| 存货 | 99,979,509.06 | 83,539,343.09 | 65,000,001.7 | 49,223,515.33 |
| 其他流动资产 | 26,317,281.22 | 24,981,917.37 | 23,135,868.58 | 20,919,255.54 |
| 流动资产合计 | 329,537,715.22 | 329,063,783.83 | 560,246,039.98 | 565,215,140.38 |
| 非流动资产: | | | | |
| 长期股权投资 | 32,287,048.18 | 32,647,448.14 | 26,232,835.39 | 29,460,396.95 |
| 其他权益工具投资 | 78,337,950 | 78,337,950 | 82,671,764.17 | 78,337,950 |
| 固定资产 | 618,573,156.2 | 624,191,221.74 | 622,357,697.28 | 630,227,765.84 |
| 在建工程 | 97,397,769.98 | 64,092,795.71 | 18,820,697.95 | 12,268,042.95 |
| 使用权资产 | 5,613,770.77 | 6,243,303.33 | 8,738,403.04 | 9,314,519.37 |
| 无形资产 | 74,513,702.7 | 76,642,166.84 | 77,582,008.81 | 77,766,630.99 |
| 开发支出 | - | - | 0 | - |
| 商誉 | 18,704,171.94 | 18,704,171.94 | 19,036,564.15 | 19,096,653.78 |
| 长期待摊费用 | 1,924,536.97 | 2,007,245.13 | 4,289,998.35 | 2,739,800 |
| 递延所得税资产 | 3,439,917.73 | 3,485,959.91 | 2,904,349.73 | 1,770,222.12 |
| 其他非流动资产 | 67,335,007.52 | 47,798,011.72 | 24,468,841.32 | 24,458,593.32 |
| 非流动资产合计 | 998,127,031.99 | 954,150,274.46 | 887,103,160.19 | 885,440,575.32 |
| 资产总计 | 1,327,664,747.21 | 1,283,214,058.29 | 1,447,349,200.17 | 1,450,655,715.7 |
| 流动负债: | | | | |
| 短期借款 | 57,767,387.08 | 67,756,747.8 | 97,736,712.32 | 97,947,315.17 |
| 应付票据及应付账款 | 97,456,667.13 | 77,287,719.88 | 70,888,791.29 | 46,039,685.95 |
| 应付账款 | 97,456,667.13 | 77,287,719.88 | 70,888,791.29 | 46,039,685.95 |
| 预收款项 | - | - | 0 | - |
| 合同负债 | 7,822,323.77 | 7,549,075.38 | 4,867,067.49 | 2,538,984.8 |
| 应付职工薪酬 | 3,993,354.2 | 7,247,265.67 | 3,872,578.6 | 3,693,756.23 |
| 应交税费 | 1,152,027.9 | 391,721.48 | 907,492.49 | 437,624.1 |
| 其他应付款合计 | 165,972,309.88 | 163,892,194.01 | 232,381,836.43 | 234,341,389.79 |
| 一年内到期的非流动负债 | 109,357,842.43 | 110,358,746.54 | 70,235,370.8 | 70,711,843.41 |
| 其他流动负债 | 7,596,738.61 | 7,653,048.3 | 70,960.1 | 82,332.17 |
| 流动负债合计 | 451,118,651 | 442,136,519.06 | 480,960,809.52 | 455,792,931.62 |
| 非流动负债: | | | | |
| 长期借款 | 88,500,000 | 88,500,000 | 197,000,000 | 167,500,000 |
| 租赁负债 | 3,731,174.69 | 3,731,174.69 | 5,938,643.58 | 6,514,759.91 |
| 递延收益 | 103,074,739.96 | 105,017,785.51 | 102,415,662.36 | 104,215,954.86 |
| 递延所得税负债 | 20,226,395.19 | 20,288,179.58 | 20,355,048.24 | 20,415,137.87 |
| 其他非流动负债 | - | - | 0 | - |
| 非流动负债合计 | 215,532,309.84 | 217,537,139.78 | 325,709,354.18 | 298,645,852.64 |
| 负债合计 | 666,650,960.84 | 659,673,658.84 | 806,670,163.7 | 754,438,784.26 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 80,000,000 | 80,000,000 | 80,000,000 | 80,000,000 |
| 资本公积 | 547,301,493.65 | 506,891,789.68 | 506,845,981.73 | 506,941,221.73 |
| 减:库存股 | 4,913,788.87 | 20,991,708.87 | 20,991,708.87 | 20,991,708.87 |
| 其他综合收益 | 1,137,272.68 | 1,137,272.68 | 1,137,272.68 | 1,137,272.68 |
| 盈余公积 | 20,260,274.89 | 20,260,274.89 | 20,260,274.89 | 20,260,274.89 |
| 一般风险准备 | - | - | 0 | - |
| 未分配利润 | -26,754,122.7 | -12,786,153.65 | 9,655,922.61 | 46,880,045.91 |
| 归属于母公司股东权益合计 | 617,031,129.65 | 574,511,474.73 | 596,907,743.04 | 634,227,106.34 |
| 少数股东权益 | 43,982,656.72 | 49,028,924.72 | 43,771,293.43 | 61,989,825.1 |
| 股东权益合计 | 661,013,786.37 | 623,540,399.45 | 640,679,036.47 | 696,216,931.44 |
| 负债和股东权益合计 | 1,327,664,747.21 | 1,283,214,058.29 | 1,447,349,200.17 | 1,450,655,715.7 |
| 公告日期 | 2026-04-29 | 2026-04-29 | 2025-10-24 | 2025-08-27 |
| 审计意见(境内) | | 标准无保留意见 | | |